For Transgender United Therapeutics CEO, Fight To Repeal NC’s HB2 Is Personal

Like many CEOs whose companies have operations in the Triangle, Martine Rothblatt is against House Bill 2, the controversial legislation that has put North Carolina at the center of the fight over transgender rights.

But unlike many of her fellow CEOs, Rothblatt has a very personal connection to the issues being raised by HB2. In addition to being CEO of United Therapeutics, a $5 billion biotechnology company that employs 300 people in Research Triangle Park, Rothblatt is also transgender.

Back to news